Meet the Innovation Centre Team

Dr Maz Ali

Research Scientist, Metabolomics Facility

Dr Maz Ali is a Research Scientist within Freedman Foundation Metabolomics Facility, Innovation Centre, Victor Chang Cardiac Research Institute. Dr Ali is experienced in metabolomics and proteomics applications in multidisciplinary research, with expertise in drug discovery, natural products and biomedical artificial intelligence applications.

Dr Ali submitted his PhD in November 2021 at NICM Health Research Institute, Western Sydney University, Australia, where he trained in Multiomics applications to decipher the synergistic and cytotoxic mechanism of anticancer drug combinations along with metabolomic profiling of herbal medicines and a wide range of pharmacological testing. In addition, Dr Ali completed his metabolomics training with Oliver Fiehn’s team at West Coast Metabolomics Centre at the University of California Davis, California, USA.

In 2017, Dr Ali worked on a collaboration project between MyHealth Test® and the University of Canberra to develop LCMS based platform analyzing hormones and vitamins from dried blood spots. Dr Ali excelled in a multiplex of chromatographic and spectrophotometric techniques since the start of his master’s in the chemistry of natural products in 2014. Dr Ali is proficient in tandem mass spectrometry-based multi-omics, including triple quadrupole, Quadrupole time of flight (QTOF) or QTOF coupled with ion mobility (IM) setups from different vendors. Dr Ali has experience in a wide range of multi-omics downstream informatics, including differential metabolites screening (PCA, OPLS-DA, PLS-DA ), clustering analyses, biomarker discovery, pathway enrichment analyses and visualization of omics data.

Dr Satya Arjunan

Scientific Software Engineer, Biomedical Data Science Facility

Dr Satya Arjunan is a Scientific Software Engineer and member of the Biomedical Data Science Facility within the Innovation Centre at the Victor Chang Cardiac Research Institute. Dr Arjunan is experienced in designing, developing, implementing, testing and maintaining scientific software applications written in a variety of languages including C/C++, Python, R and Matlab. He is experienced in performing statistical analyses and implementing scientific applications that can exploit high-performance computing resources using pthread, MPI and CUDA libraries.

In 2009, Dr Arjunan received his PhD in Systems Biology from Keio University, Japan, where he worked on modelling and simulating reaction-diffusion dynamics of bacterial cell division regulators at single-molecule resolution. During his postdoctoral work at the RIKEN Center for Biosystems Dynamics Research in Japan (2010-2018), he studied the mechanisms of PIP3/PTEN travelling waves in amoeba and kinesin-microtubule dynamics in neurons during development using advanced 3D simulation and visualisation approaches that he developed.

Prior to joining Victor Chang Cardiac Research Institute, he was a research fellow at the UNSW Lowy Cancer Research Centre (2018-2021), where he developed a multi-scale simulator to capture 3D lymphocyte migration dynamics in silico. He has also performed statistical analyses and applied machine learning approaches to construct realistic models of lymphocyte migration in 3D collagen matrix.

Dr Johanna Barclay

Head of Scientific Innovation
Senior Manager, Innovation Centre

Dr Johanna Barclay is the Head of Scientific Innovation and Senior Manager of the Innovation Centre at the Victor Chang Cardiac Research Institute. She has a background in biomedical research, research strategy and partnerships, and business strategy.

Dr Barclay completed a PhD in 2007 from the University of Queensland and undertook postdoctoral positions at the Institute of Molecular Biosciences (Queensland), the Max Plank Institute for Biophysical Chemistry (Germany), and the Translational Research Institute (Queensland). She has 51 peer-reviewed publications which have been cited more than 1600 times. Dr Barclay transitioned to research strategy in 2016, managing the Strategic Development team at Mater Research (Queensland) to facilitate all aspects of research funding and metrics, and develop complex strategic partnerships between research and health sectors. In 2018 Dr Barclay joined the University of New South Wales as Senior Research Development Manager in the Research Strategy Office, leading a team to develop competitive funding strategies in all disciplines across the University. She served as board member for the Australasian Research Management Society (ARMS) in 2018, and again in 2019 as Deputy Director. Dr Barclay was awarded her MBA from the University of Queensland in 2020.

Dr Barclay joined the Victor Chang Cardiac Research Institute in December 2019 where her role encompasses the facilitation of strategic projects and partnerships for the Institute, as well as the management, development, growth and promotion of the Innovation Centre.

Dr David Humphreys

Senior Research Scientist, Biomedical Data Science Facility

Dr David Humphreys is a multidisciplinary wet-lab/bioinformatician scientist and a senior member of the Biomedical Data Science Facility within the Innovation Centre.

Dr David Humphreys completed his BSc(Hons) and PhD at the University of Wollongong through the department of cell and molecular biology. In his undergraduate years he also completed course work to fulfill a joint major in computer science. Dr Humphreys then joined the Victor Chang Cardiac Research Institute as a postdoc researcher in 2000 and developed a research interest in post transcriptional gene regulation involving microRNAs. Between 2009 and 2011 Dr Humphreys played a pivotal role in establishing the first high throughput sequencer at the VCCRI where he performed library prep and bioinformatic analysis. He then managed the Genome Core Facility which enabled him to collaborate with many research groups within VCCRI.

Dr Humphreys works closely with both researchers and clinicians and has extensive experience with a wide range of bioinformatic analysis, particularly with high throughput sequencing data sets. These include both DNA-Sequencing (eg Whole genome, whole exome, Chip Seq, ATAC Seq) and RNA-Sequencing (eg single cell RNA-Seq, miRNA-Seq, whole transcriptome, circle RNA, tRNA). Dr Humphreys has also developed various bioinformatic tools that help visualise trends within these complex data sets (eg miRspring, Ularcirc, Sierra).

Esther Kristianto

Research Scientist, Metabolomics Facility

Esther Kristianto has lengthy experience working with mass spectrometry (MS) instrumentation. She completed her BSc in Applied Chemistry at the University of Technology Sydney in 2007, training in multiresidue analysis.

In 2011, Kristianto joined the South Australian node of Metabolomics Australia, housed within the Australian Wine Research Institute (AWRI). She was responsible for performing targeted analysis of metabolites in grapes and wines, as well as facilitating new method development in other biological matrices using GC-MS, LC-MS/MS and LC-qTOF.

Kristianto later returned to Sydney and joined the newly established Metabolomics Facility in the Victor Chang Cardiac Research Institute Innovation Centre. She operates the LC-MS/MS instruments for targeted metabolomics analysis and work closely and collaboratively with researchers and students to develop new workflows and methods for their projects.

Dr Jeffrey McArthur

Assistant Manager
Head, Cell Function & Screening Facility

Dr Jeffrey McArthur is the Head of the Cell Function & Screening Facility within the Innovation Centre at the Victor Chang Cardiac Research Institute and the facility's Assistant Manager. Dr McArthur is an experienced electrophysiologist, with expertise in ion channels underlying cellular excitability and various electrophysiological techniques to study them.

He completed his PhD in 2011 from the University of Calgary, Canada, where he trained in electrophysiological methods to study ion channels. Research fellow positions at RMIT University (2011-13) and Harvard University (2013-16) provided him with experience in Cav channels involved in sensory perception.

In 2019, while still developing his independent research on calcium channels, he joined the Victor Chang Cardiac Research Institute, as Head of the Cell Function & Screening Facility. Dr McArthur brings valuable experience in ion channel physiology and pathophysiology as well as various electrophysiological methods, evidenced by his 24 publications in well-respected physiology/pharmacology journals.

Dr Scott Page

Head, Micro Imaging Facility

Dr Scott Page is the Head of the Micro Imaging Facility at the Victor Chang Cardiac Research Institute Innovation Centre. Dr Page is an experienced microscopist, with significant expertise in fluorescence and confocal microscopy, 3D and live cell microscopy, electron microscopy and in silico post-processing and analysis.

Dr Page completed his PhD in Molecular and Human Genetics in 1998 at Baylor College of Medicine, USA, where he first utilised fluorescence microscopy. During his postdoctoral work in the USA he used a variety of microscopy techniques to study the molecular mechanisms of chromosome behaviour in meiosis. He then relocated to Australia in 2006, where he has worked at James Cook University (2006-09) and Children’s Medical Research Institute (2009-14), investigating various aspects of mitotic cell division while further developing his skills across several microscopy techniques, including live fluorescence and confocal microscopy, 3D imaging and automated high-throughput microscopy, as well as an interest in training researchers in imaging methods.

From 2014-2020, Dr Page was the Manager of the ACRF Telomere Analysis Centre where he established and led the Advanced Microscopy Centre at the Children’s Medical Research Institute. In 2021, Dr Page took up leadership of the Micro Imaging Facility at the Victor Chang Cardiac Research Institute Innovation Centre. He collaborates with scientists, providing research support and training in specimen preparation, image acquisition, and post-processing and analysis of microscopy data obtained with the facility’s state-of-the-art instruments.


Liam Reynolds

Research Scientist, Stem Cell Production Facility

Liam Reynolds is a research scientist with experience in human induced pluripotent stem cells (iPSCs) including reprograming, culture and differentiation into a variety of cell types. He holds a Bachelor of Biomedical Science (Hons) awarded by the University of Queensland in 2019.

In 2019, Liam joined the Cardiac Bioengineering laboratory at QIMR Berghofer where he completed his honours thesis under the supervision of James Hudson. He was responsible for cardiac and endothelial differentiation from human iPSCs and worked to further the maturity of cardiac tissue that can be created ex vivo. He was involved in developing methodologies for the manufacture of large, human iPSC-derived cardiac tissue formats- an emerging and exciting therapy for cardiovascular disease.

Liam works in the Stem Cell Production Facility sharing his iPSC expertise with the facility users. He also works with users of the facility to develop robotic platforms, organoid models and gene editing methodologies to enhance their research.

Dr Pallavi Srivastava

Research Scientist, Stem Cell Production Facility

Dr. Pallavi Srivastava is a Research Scientist in the Stem Cell Production Facility within the Innovation Centre at the Victor Chang Cardiac Research Institute. She is an experienced Stem Cell Biologist and has worked with handling and derivation of a variety of adult and pluripotent stem cells. Her background includes cell and molecular biology, as well as immunological techniques, and fluorescence imaging..

Pallavi completed her Doctor of Philosophy (Ph.D.) in 2022 within the School of Medical Sciences and School of Chemistry at the University of New South Wales, Sydney. Her Ph.D. involved developing biomaterials-based platforms to study the biophysical effects of varied culture substrates on the differentiation and self-organisation abilities of human pluripotent stem cells. Along with utilising her stem cell biology experience, this role also introduced her to basics of materials chemistry as well as 3D cell culture methods and organoid derivation.

She received a Master of Science (MSc) degree by research from All India Institute of Medical Sciences in 2014. She worked as a research assistant and lab manager at an evolutionary genetics lab in Nanyang Technological University (NTU), Singapore that used human and chimp iPSCs for their models. She completed her Honours degree from Sam Higginbottom Institute of Agriculture, Technology and Sciences, India in 2011 majoring in Genetic Engineering and completed the final year project for this degree at Genome Institute of Singapore. A*STAR, Singapore in 2011.

Dr Nana Sunn

Head, Preclinical Imaging Facility

Dr Nana Sunn is the Head of the Preclinical Imaging Facility within the Innovation Centre at the Victor Chang Cardiac Research Institute. Dr Nana Sunn is an experienced preclinical imaging scientist and manager of imaging core facilities providing multimodality imaging research support and training to researchers across the disciplines.

Prior to joining the Victor Chang Cardia Research Institute, Dr Sunn setup and established preclinical imaging facilities at the University of Sydney (Sydney Imaging Core Research Facility, 2014-2021), Translational Research Institute (UQ, 2011-2014), and Queensland Brain Institute (UQ, 2006-2011).

She undertook her Postdoc Fellowships in neuroscience at The Douglas Research Centre, McGill University (2002-2003) and cardiovascular physiology, stem cells therapy & developmental biology in women & infant health at The Samuel Lunenfeld Research Institute at Mount Sinai Hospital, University of Toronto (2003-2006). With the extensive University Health Network (UHN) as her training ground in Toronto that included The Centre of Phenogenomics (a state-of-the-art national research facility for animal models of human diseases), Mouse Imaging Centre of Excellence (state-of-the-art medical imaging technologies for characterisation of mouse functional genomics), MaRS Discovery District and operating multimodal preclinical imaging facilities,

Dr Sunn has worked closely with researchers, clinicians and clinician scientists including industry partners in preclinical imaging studies. The range of preclinical imaging technology that Dr Sunn has managed included: 7T MRI, 3T PET/MR, PET/CT, micro-ultrasound with photoacoustic imaging, 3D in vivo microCT, optical bioluminescence/fluorescence imaging, 2D Xray with Dual Energy Absorptiometry camera and body composition analyser in awake animal.

Paul Young

Senior Research Officer, Biomedical Data Science Facility

Paul Young is a bioinformatician with a background in both biology and computing. His bioinformatic experience encompasses broad areas of genomics including transcriptomics, epigenomics and genomic risk analysis.

Young completed his undergraduate studies in Molecular Genetics in 1999 followed by a Masters in Biopharmaceuticals before completing postgraduate studies in Computer Science at the University of New South Wales in 2006. In 2009, Young joined the Victor Chang Cardiac Research Institute, initially working as laboratory manager, combining wet lab research and bioinformatics. His laboratory background has provided him experience across a number of fields including novel drug screening, molecular diagnostics, epigenetics and others. Paul has experience with the use of state-of-the-art equipment including HPLCs, qPCRs and next generation sequencers.

In 2018, he joined the Victor Chang Genome Core as an institute bioinformatician providing his expertise to multiple research groups within the Institute, to collaborators and external researchers. He has experience in the analysis of genomic data sets from various sequencing technologies (smallRNASeq, RNASeq, singleCellRNASeq, methylSeq and DNAseq) as well as several array platforms for genotyping and methylation analysis. Young’s accomplishments include coding software tools for the analysis of small RNA data sets, the prioritisation of genomic variants and developing specialised qPCR assay design software. Pauls’ expertise has allowed him to contribute to several patent applications, as well as >20 scientific publications. Paul is a member of the Biomedical Data Science Facility within the Innovation Centre, deploying his considerable breadth of expertise in support of user's projects.

Acknowledgement of Country

The Victor Chang Cardiac Research Institute acknowledges the traditional custodians of the land, the Gadigal of the Eora nation, on which we meet, work, and discover.
Our Western Australian laboratories pay their respect to the Whadjuk Noongar who remain as the spiritual and cultural custodians of their land.

Close